Lenvatinib: A Review in Hepatocellular Carcinoma

Overview of attention for article published in Drugs, April 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 1 X user

patent: 5 patents

Readers on

mendeley: 112 Mendeley

Summary X Patents

So far, Altmetric has seen 1 X post from an account with 297 followers.

Our latest @AdisJournals Drug Evaluation on #Lenvatinib in Hepatocellular Carcinoma #HCC https://t.co/If3VxqxgwF

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.